Stockreport

Novavax hits a 52-week high as Sanofi deal prompts J.P. Morgan upgrade [Seeking Alpha]

Sanofi - American Depositary Shares  (SNY) 
US:NYSE Investor Relations: sanofi.com/en/investors
PDF on the back of a licensing deal with Sanofi ( SNY ), drawing an upgrade from J.P. Morgan. The deal linked to the company's COVID-19 vaccine and valued at up to $1.2B, [Read more]